RIGL
NASDAQStockRigel Pharmaceuticals, Inc.
$25.86-0.74 (-2.78%)
52-Week Range
$16.26
$50.96
Key Stats
Market Cap
469.4M
P/E Ratio
1.33
Dividend Yield
—
Beta
1.17
Volume
203.5K
Avg Volume
471.0K
Performance
1M
-22.27%
3M
-37.38%
6M
-28.69%
YTD
-36.41%
1Y
+32.14%
3Y
+64.20%
5Y
-36.82%
Price Chart
ETF Exposure
RIGL is held by 87 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FDM | First Trust Dow Jones Select MicroCap Index Fund | 0.71% |
| LITL | Simplify Piper Sandler US Small-Cap PLUS Income ETF | 0.52% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.51% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.50% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 0.37% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.32% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 0.32% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.30% |
| CURE.AX | Global X - S&P Biotech ETF | 0.25% |
| XBI | State Street SPDR S&P Biotech ETF | 0.25% |
| BFOR | Barron's 400SM ETF | 0.21% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.17% |
| JPSE | JPMorgan Diversified Return U.S. Small Cap Equity ETF | 0.13% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.13% |
| IWC | iShares Micro-Cap ETF | 0.10% |
| STSB | iShares Factors US Small Blend Style ETF | 0.10% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.08% |
| FSML | Franklin Small Cap Enhanced ETF | 0.08% |
| EES | WisdomTree U.S. SmallCap Fund | 0.08% |
| PSC | Principal U.S. Small-Cap Multi-Factor ETF | 0.07% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.07% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.07% |
| CALF | Pacer US Small Cap Cash Cows ETF | 0.07% |
| PWS | Pacer WealthShield ETF | 0.07% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.05% |
| AVUV | Avantis U.S. Small Cap Value ETF | 0.05% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.04% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.04% |
| IWO | iShares Russell 2000 Growth ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.02% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.02% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.02% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
Page 1 of 2Next
About RIGL ETF Exposure
Rigel Pharmaceuticals, Inc. (RIGL) is held by 87 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 469.4M, RIGL is a widely held institutional stock. The stock currently trades at $25.86. Investors can gain exposure to RIGL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RIGL, sorted by portfolio weight.